Inhibrx Biosciences, Inc.

Net buying: insiders sold $279K and bought $6.3M of INBX stock on the open market in the 90 days to Oct 31, 2026, according to SEC Form 4 filings. The largest was Lappe, Mark (Chief Executive Officer), who bought $4.5M. The latest filing was on Oct 14, 2026.

None. No member of Congress disclosed a INBX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.